Modification of RNA produced by in vitro transcription may be necessary to improve RNA transcript stability, encourage efficient translation in eukaryotic systems, or to label the 5' ends of the RNA. We offer the following post-transcriptional RNA modification enzymes: Vaccinia Capping Enzyme and mRNA Cap 2'-O-Methyltransferase.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.